Filing Details

Accession Number:
0001513162-20-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-17 15:46:15
Reporting Period:
2020-03-13
Accepted Time:
2020-03-17 15:46:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
715446 Anixa Biosciences Inc ANIX Services-Medical Laboratories (8071) 112622630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1499254 Jr H Lewis Titterton C/O Anixa Biosciences, Inc.
3150 Almaden Expressway, Suite 250
San Jose CA 95118
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-13 5,799 $2.12 924,743 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct